Table 1 Summary of baseline visit visual acuity data and ulcer size, epithelization times in both treatment groups, and mean follow-up time and visual acuities at discharge visit
Baseline visit | Medication group (n = 21) | PACK-CXL group (n = 18) | P-value |
|---|---|---|---|
Mean (SD) | Mean (SD) | ||
Ulcer size (mm) | 2.33 (0.87) | 2.75 (1.07) | 0.1564 |
UCVA (logMAR) | 1.15 (1.03) | 1.24 (0.90) | 0.494 |
CDVA (logMAR) | 0.73 (0.85) | 0.76 (0.66) | 0.453 |
Epithelization time (days) | Medication group (n = 19) | PACK-CXL group (n = 16) | P-value |
|---|---|---|---|
Median | 7 | 7 | 0.828 |
Q75% | 20.5 | 10 | |
Q90% | 37 | 19.6 | |
Maximum | 50 | 28 | |
Mean (SD) | 14.58 (14.95) | 9.94 (7.18) |
Epithelization time difference between both groups | |||
|---|---|---|---|
Difference (PACK-CXL-med) | − 4.64 | ||
Pooled SD | 12.06 | ||
Error margin | 8.02 | ||
CI (95%) | (− 12.66, 3.38) | ||
Discharge visit | Medication group (n = 19) | PACK-CXL group (n = 16) | P-value |
|---|---|---|---|
Mean (SD) | Mean (SD) | ||
Therapy/follow-up duration (days) | 29.42 (12.60) | 22.56 (3.82) | |
UCVA (logMAR) | 1.00 (1.06) | 0.79 (0.68) | 0.96 |
CDVA (logMAR) | 0.54 (0.75) | 0.53 (0.68) | 0.96 |